Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliograf¿a
[1]
Banting lectura 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
[2]
NCEP-Defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52:1210-4.
[3]
The Metabolic syndrome as predictor of type 2 diabetes. The San Antonio Heart Study. Diabetes Care. 2003;26:3153-9.
[4]
Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
[5]
Epidemic obesity and the metabolic syndrome. Circulation. 2003;108:1541-5.
[6]
Epidemia de enfermedades metabólicas. Una llamada de atención. Med Clin (Barc). 2003;120:99-100.
[7]
Abdominal obesity, insulin resistanse, and metabolic syndrome in a southern European population. Eur J Intern Med. 2003;14:101-6.
[8]
Resistencia a la insulina y su implicación en múltiples factores de riesgo asociados a diabetes tipo 2. Med Clin (Barc). 2002; 119:458-63.
[9]
Síndrome metabólico, resistencia a la insulina y diabetes. ¿Qué se oculta bajo la punta del iceberg? Aten Primaria. 2003;31:436-45.
[10]
Diabetes mellitus y riesgo cardiovascular: recomendaciones del Grupo de Trabajo Diabetes Mellitus y Enfermedad Cardiovascular de la Sociedad Española de Diabetes. Clin Invest Arterioscl. 2004;16:74-8.
[11]
Síndrome metabólico. Guías Clínicas. 2005;5(2). Disponible en: http://www.fisterra.com/guias2/smetabolico.asp
[12]
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34:416-22.
[13]
Relationship between obesity, insulin resistance, and coronary heart disease risk. J Amm Coll Cardiol. 2002;40:937-43.
[14]
Executive summary of The Third Report of the National Cholesterol Education Program (NCEP). JAMA. 2001;285:2486-97.
[15]
The metabolic syndrome and chronic kideney disease in US adults. Ann Intern Med. 2004;140:167-74.
[16]
Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109:2818-25.
[17]
Cuantificación de insulinorresistencia con los valores de insulina basal e índice HOMA en una población no diabética. Med Clin (Barc). 2001;117:530-3.
[18]
Predictors of the incident metabolic syndrome in adults. The Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004; 27:788-93.
[19]
Consensus Development Conference on Insulin Resistance. Diabetes Care. 1997;21:310-4.
[20]
Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002;28:364-76.
[21]
Identification of subjects with insulin resistance and b-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes. 2003;52:2740-7.
[22]
American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:237-52.
[23]
Definition of Metabolic Syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on Scientific Issues Related to Definition. Circulation. 2004;109:433-8.
[24]
Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.
[25]
Abdominal obesity and the risk of coronary artery disease. Can J Cardiol. 1992;8:561-2.
[26]
Abdominal obesity as an important component of insulin-resistance syndrome. Nutrition. 1993;9:452-9.
[27]
The metabolic syndrome. Practical Guide to Origins and Treatment. Circulation. 2003;108:1422-5, 1537-40.
[28]
The metabolic syndrome. More than the sun of its parts? Circulation. 2003;108:1546-51.
[29]
Metabolic syndrome epidemic. Circulation. 2003;108:1552-3.
[30]
Cardiovascular outcomes for obesity and metabolic syndrome. Obes Res. 2002;10 Suppl 1:27-32.
[31]
The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prevent Rehab. 2004;11:3-8.
[32]
Clinical Management of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on Scientific Issues Related to Definition. Circulation. 2004;109:551-6.
[33]
Salying the metabolic syndrome. Are we battling the hydra or the chimera? Minerva Endocrinol. 2004;29:89-111.
[34]
Consenso SEEDO'2000 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica. Med Clin (Barc). 2000;115:587-97.
[35]
Management of Obesity in Diabetes. Clinical Practice Guidelines. 2003;S46-9.
[36]
The JNC 7 Report. JAMA. 2003;289:2570-2.
[37]
Antihypertensive therapy and incidence of type 2 diabetes. A systematic review. Diabetes Care. 2004;27247-55.
